Nunzia Pharmaceutical Company

OTC: NUNZ · Healthcare · Medical - Pharmaceuticals

PublicHQ Long Beach, CA · Los AngelesCIK 0000886093Reports USD

#1161 of 1,418 Healthcare companies by revenue

EA Score

——

FH —DQ 4GM —SS 34

v0.1 · 25/100 weight · pillars only

↑ listing tenure, Piotroski F · ↓ return on assets, filing timeliness

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$78.1M

Employees

as of 2026-08-28

Market cap

$43.5k

as of 2026-08-28

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$0$02021

Net income-$78.1M-$78.1M2021

Operating income-$78.1M-$78.1M2021

Total assets$5.1k$5.1k2021

Liabilities$99.3k$99.3k2021

Equity-$94.2k-$94.2k2021

Revenue trend

FY2020 – FY2021 · USD

FY20

FY21

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Nunzia Pharmaceutical Company’s revenue?

Nunzia Pharmaceutical Company booked $0 in FY2021 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Hero Technologies Inc.——Nascent Biotech, Inc.——SOAFEE, Inc.——Bright Green Corporation——Wellness Matrix Group, Inc.——Health Advance Inc.——

Neighbors

Los Angeles →

The Walt Disney Company$94.4B72B Public Storage$4.8B80B+Southern California Gas Company PFD SER A 6%——Ares Management Corporation$5.6B68B Live Nation Entertainment, Inc.$25.2B76B+Rocket Lab USA, Inc.$601.8M50D

Key facts

CEOSara Gonzales

SectorHealthcare

IndustryMedical - Pharmaceuticals

HeadquartersLong Beach, CA

ExchangeOTC: NUNZ

Employees4

IPO date2009-07-24

Latest filings

10-Q2022-11-14 10-Q2022-10-03 10-Q2022-05-23 10-K2022-04-15 8-K2022-03-18 8-K2022-03-02 10-Q2021-11-10 10-Q2021-09-17

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.